PRAC reviews ambroxol and bromhexine safety

15 April 2014 - Deborah Wilkes

Archived

Safety concerns have prompted the European Union's Pharmacovigilance Risk Assessment Committee (PRAC) to start a review of the expectorants ambroxol and bromhexine, which are the active ingredients of Boehringer Ingelheim's Bisolvon, Mucoangin and Mucosolvan brands.

Click tags below for more information on topics:

FAMHP

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: